Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Applying new proteomic technologies to improve patient management

Share :

SABCS 2009

9 - 13 Sep 2009
Published: 27 Jan 2010
Views: 9356
Rating:
Save
Dr Gordon Mills - University of Texas MD Anderson Cancer Center, Houston, USA
Dr Gordon Mills discusses the need to apply new proteomic technologies to improve patient management.

Related Videos

Pembrolizumab improves breast cancer outcomes regardless of age or menopausal...
Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain
Pembrolizumab improves breast cancer outcomes regardless of age or menopausal status ( Dr Javier Cortes - International Breast Cancer Center, Barcelona, Spain )
26 Mar 2024
Exercise positively effects symptom burden and quality of life of metastatic...
Dr Anouk Hiensch - UMC Utrecht, Utrecht, Netherlands
Exercise positively effects symptom burden and quality of life of metastatic breast cancer patients ( Dr Anouk Hiensch - UMC Utrecht, Utrecht, Netherlands )
25 Mar 2024
Using AI to identify patients at increased risk of side effects from radiation...
Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK
Using AI to identify patients at increased risk of side effects from radiation treatment for breast cancer ( Dr Tim Rattay - University of Leicester Cancer Research Centre, Leicester, UK )
25 Mar 2024
Implementation of the Choosing Wisely Africa List in 3 Countries
Dr Sarah Kutika Nyagabona - Muhimbili National Hospital, Dar es Salaam, Tanzania
Implementation of the Choosing Wisely Africa List in 3 Countries ( Dr Sarah Kutika Nyagabona - Muhimbili National Hospital, Dar es Salaam, Tanzania )
16 Jan 2024
Adding atezolizumab to adjuvant chemotherapy for stage II and III triple...
Dr Michail Ignatiadis - Institut Jules Bordet, Brussels, Belgium
Adding atezolizumab to adjuvant chemotherapy for stage II and III triple-negative breast cancer is unlikely to improve efficacy ( Dr Michail Ignatiadis - Institut Jules Bordet, Brussels, Belgium )
15 Jan 2024
T-DM1 shows promise in treating unresectable locally advanced or metastatic...
Dr Sara Hurvitz - University of Washington, Seattle, USA
T-DM1 shows promise in treating unresectable locally advanced or metastatic HER2-positive breast cancer ( Dr Sara Hurvitz - University of Washington, Seattle, USA )
10 Jan 2024
ASCO and its Sub-Saharan African outreach programme
Dr Julie Gralow - Chief Medical Officer, American Society of Clinical Oncology...
ASCO and its Sub-Saharan African outreach programme ( Dr Julie Gralow - Chief Medical Officer, American Society of Clinical Oncology (ASCO), USA )
10 Jan 2024
CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer
Dr Sitna Mwanzi - Kenyatta National Hospital, Nairobi, Kenya
CDK-4/6 inhibitors with endocrine treatment for metastatic breast cancer ( Dr Sitna Mwanzi - Kenyatta National Hospital, Nairobi, Kenya )
10 Jan 2024
SABCS 2023: Highlights
Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy
SABCS 2023: Highlights ( Dr Matteo Lambertini - San Martino Hospital, Genoa, Italy )
2 Jan 2024

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation